1995-04-20
Comparison of chop chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma
Publication
Publication
New England Journal of Medicine , Volume 332 - Issue 16 p. 1045- 1051
High-dose chemoradiotherapy combined with autologous bone marrow transplantation can cure patients with disseminated, aggressive non-Hodgkin's lymphoma in whom first-line chemotherapy has failed. In contrast, cure is rare with second-line chemotherapy. It has been suggested that patients with slow responses to the initial phase of first-line chemotherapy are at high risk for relapse. Therefore, such patients are potential candidates for early bone marrow transplantation.
| Additional Metadata | |
|---|---|
| doi.org/10.1056/NEJM199504203321601, hdl.handle.net/1765/58548 | |
| New England Journal of Medicine | |
| Organisation | Department of Hematology |
|
Verdonck, L., van Putten, W., Hagenbeek, A., Schouten, H., Sonneveld, P., van Imhoff, G., … Löwenberg, B. (1995). Comparison of chop chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. New England Journal of Medicine, 332(16), 1045–1051. doi:10.1056/NEJM199504203321601 |
|
